Cepharanthin ( DrugBank: Cepharanthin )


1 disease
IDDisease name (Link within this page)Number of trials
53Sjogren syndrome3

53. Sjogren syndrome


Clinical trials : 305 Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000019242
2015/10/0706/10/2015Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patientsStudy on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients - Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients Sjogren's syndromecepharanthin, salagenDepartment of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate SchoolNULLRecruiting20years-old90years-oldMale and Female10Not applicableJapan
2JPRN-jRCTs061180072
11/08/201119/03/2019Cepharanthine trialClinicopathological study on the efficacy of Cepharanthine for preventing salivary gland destruction in Sjogren's syndrome patients - Cepharanthine trial SjSCepharanthine (6 mg / day) administrationYamanoi TomokoNULLComplete>= 20age oldNot applicableBoth25Phase 2-3Japan
3JPRN-UMIN000005878
2011/07/0131/07/2011Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patientsClinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patients - Effectiveness of cepharanthin on the acinar structure Sjogren's syndromecepharanthinDepartment of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of DentistryNULLRecruiting20years-old90years-oldMale and Female10Not applicableJapan